Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 and 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02127762
What this trial is testing

The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy

Who this might be right for
Diabetes MellitusType I DiabetesType II Diabetes+2 more
Ottawa Hospital Research Institute 81
Not applicableLooking for participantsNCT07065383
What this trial is testing

Rebalancing the Fat Content of the Heart and Muscles

Who this might be right for
Diabetes Mellitus Type 2
University of Aberdeen 60
Not applicableEnded earlyNCT02080741
What this trial is testing

Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Who this might be right for
Patients With Type 1 or Type 2 DiabetesPatients With a Type A or B Behaviour Profile
Centre Hospitalier Universitaire Dijon 57
Not applicableEnrolling By InvitationNCT07122180
What this trial is testing

Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
MDCECRO LLC 72
Not applicableStudy completedNCT05653050
What this trial is testing

Closing the Loop in People with Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Cambridge 26
Post-approval studies (Phase 4)Looking for participantsNCT07159282
What this trial is testing

A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers

Who this might be right for
Diabetic FootFoot UlcerUlcer Foot+4 more
Applied Biologics, LLC 60
Testing effectiveness (Phase 2)WithdrawnNCT01828125
What this trial is testing

Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal
Not applicableStudy completedNCT01579981
What this trial is testing

The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects

Who this might be right for
Type 2 Diabetes
Hvidovre University Hospital 9
Post-approval studies (Phase 4)Study completedNCT00168857
What this trial is testing

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

Who this might be right for
HypertensionDiabetic Nephropathies
Boehringer Ingelheim 860
Early research (Phase 1)Study completedNCT04744636
What this trial is testing

Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Institut de Recherches Internationales Servier 100
Post-approval studies (Phase 4)Study completedNCT01013571
What this trial is testing

Self Titration With Apidra to Reach Target Study (START)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 493
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06227221
What this trial is testing

Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
Second Xiangya Hospital of Central South University 10
Testing effectiveness (Phase 2)Study completedNCT00461136
What this trial is testing

Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes

Who this might be right for
Diabetes Type 2
Novartis 18
Not applicableStudy completedNCT00655044
What this trial is testing

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 3,637
Not applicableStudy completedNCT01991548
What this trial is testing

User Evaluation of the MiniMed 640G Insulin Pump

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Medtronic MiniMed, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT02265809
What this trial is testing

Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Cambridge University Hospitals NHS Foundation Trust 41
Early research (Phase 1)Study completedNCT06279234
What this trial is testing

Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Obesity
Pfizer 50
Not applicableStudy completedNCT01774565
What this trial is testing

Closed-loop Insulin Delivery in the General Ward

Who this might be right for
Diabetes Mellitus
University of Cambridge 43
Early research (Phase 1)Looking for participantsNCT07570992
What this trial is testing

A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM

Who this might be right for
Healthy VolunteersDiabetes Mellitus, Type 2
Novo Nordisk A/S 58
Not applicableUnknownNCT06040463
What this trial is testing

Improving Diabetes Equity and Advancing Care Study

Who this might be right for
DiabetesDiabetes MellitusDiabetes Mellitus, Type 1+1 more
Sinai Health System 270
Next Page